Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the bacopa monniera extract: Potential implication in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 229-247

  Singh, Manjeet ^a   Murthy, Ven ^b   Ramassamy, Charles ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Alzheimer's disease; Bacopa monniera; mitochondria; oxidative stress; redox regulation

Indexed keywords

ACROLEIN; BACOPA MONNIERI EXTRACT; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; GLUTATHIONE; LACTATE DEHYDROGENASE; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALZHEIMER DISEASE; ARTICLE; BACOPA MONNIERI; CELL SURVIVAL; CELL VIABILITY; CELLULAR STRESS RESPONSE; CYTOTOXICITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; BACOPA; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; GENE EXPRESSION REGULATION; METABOLISM; NEUROBLASTOMA; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN CARBONYLATION; TIME; TUMOR CELL LINE;

ACROLEIN; BACOPA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRON TRANSPORT COMPLEX I; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEUROBLASTOMA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 77954982065     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091729     Document Type: Article

References (85)

1. Gibson GE, Starkov A, Blass JP, Ratan RR, M Beal MF (2010) Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 1802, 122-134.
2. Bennett S, Grant MM, Aldred S (2009) Oxidative Stress in Vascular Dementia and Alzheimer's disease: A Common Pathology. J Alzheimers Dis 17, 245-257.
3. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103, 373-383.
4. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060.
5. Lovell MA, Markesbery WR (2007) Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 35, 7497-7504.
6. Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ (2008) Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med 45, 219-230.
7. Lovell MA, Xie C, Markesbery WR (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194.
8. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 27, 1094-1099.
9. Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72, 751-756.
10. Liu X, Lovell MA, Lynn BC (2005) Development of a method for quantification ofacrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal Chem 77, 5982-5989.
11. Liu X, Lovell MA, Lynn BC (2006) Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry. Chem Res Toxicol 19, 710-718.
12. Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G (2001). Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 55, 125-132.
13. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827.
14. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. J Biochem 38, 7609-7616. (Pubitemid 29289332)
15. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brin-ton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 14670-14675.
16. Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D (2002) Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 32, 1076-1083.
17. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 94, 2642-2647.
18. Huang Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) NF-kappaB precursor, p105, and NF-kappaB inhibitor, Ikap-paBgamma, are both elevated in Alzheimer disease brain. Neu-rosciLett 373, 115-118.
19. Sung S, Yang H, Uryu K, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VM, Pratico D (2004) Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am J Pathol 165, 2197-2206.
20. Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW (2009) Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience 162, 1220-1231.
21. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ (2006) ERK1/2 activation mediates Aft oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281, 20315-20325.
22. Ruffels J, Griffin M, Dickenson JM (2004) Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death. Eur J Pharmacol 483, 163-173.
23. Smith WW, Norton DD, Gorospe M, Jiang H, Nemoto S, Holbrook NJ, Finkel T, Kusiak JW (2005) Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity. Cell Biol 169, 331-339.
24. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci GP (2005) Electron transfer between cytochrome c and pS6Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-233.
25. Holzer M, Rodel L, Seeger G, Gartner U, Narz F, Janke C, Heumann R, Arendt T (2001) Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cy-toskeletal proteins and dendritic morphology. Neuroscience 105, 1041-1054. (Pubitemid 32786816)
26. Garver TD, Oyler GA, Harris KA, Polavarapu R, Damuni Z, Lehman RA, Billingsley ML (1995) Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. Mol Pharmacol 47, 745-756.
27. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M (2001) Incidence of Alzheimer's disease in a rural community in India. Neurology 57, 985-989.
28. Howes MJ, Houghton PJ (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75, 513-527.
29. Russo A, Borrelli F (2005) Bacopa monniera, a reputed nootropic plant: an overview. Phytomed 12, 305-317.
30. Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K (2008) Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol 120, 112-117.
31. Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV (2006) Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis 9, 243-251.
32. Ba F, Pang PK, Benishin CG (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J Neurosci Methods 123, 11-22.
33. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Grone-meyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nunez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorra-no L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vanden-abeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16, 1093-1107.
34. Page B, Page M, Noel C (1993) A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3, 473-476.
35. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421-5426.
36. Luo C, Wang X, Long J, Liu J (2006) An NADH-tetrazolium-coupled sensitive assay for malate dehydrogenase in mitochondria and crude tissue homogenates. J Biochem Biophys Methods 68, 101-111.
37. Kaczara P, Sarna T, Burke JM (2010) Dynamics of H2O2 availability to ARPE-19 cultures in models of oxidative stress. Free Radic Biol Med 48, 1064-1070.
38. Mubeen AA, Jeffrey NK, Stephen WS (2008) Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic Biol Med 45, 1510-1519.
39. HamannK, Shi R (2009) Acrolein scavenging: apotentialnov-el mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem 111, 1348-1356.
40. Kooy NW, Royall JA, Ischiropoulos H (1997) Oxidation of 2/, 7/-dichlorofluorescin by peroxynitrite. Free Radic Res 27, 245-254.
41. Lim HM, Xu D, Lippard SJ (2006) Visualization of nitric oxide in living cells by a copper-based fluorescent probe. Nat Chem Biol 2, 375-380.
42. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287, C817-C833.
43. Roy J, Pallepati P, Bettaieb A, Tanel A, Averill-Bates DA (2009) Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem Biol Interact 181, 154-167.
44. Luo J, Robinson JP, Shi R (2005) Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int 47, 449-457.
45. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mito-chondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
46. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drosee S, Brandt U, Savaskan E, Czech C, Gotz J, Eckert A (2009) Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 106, 20057-20062.
47. Gertz M, Fischer F, Wolters D, Steegborn C (2008) Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Nat Acad Sci USA 105, 5705-5709.
48. Fratelli M, Goodwin LO, 0rom UA, Lombardi S, Tonelli R, Mengozzi M, Ghezzi P (2005) Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Nat Acad Sci USA 102, 13998-14003.
49. Cimini A, Moreno S, D'Amelio M, Cristiano L, D'Angelo B, Falone S, Benedetti E, Carrara P, Fanelli F, Cecconi F, Ami-carelli F, Ceru MP (2009) Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. J Alzheimers Dis 18, 935-952.
50. Shen C, Chen Y, Liu H, Zhang K, Zhang T, Lin A, Jing N (2008) Hydrogen peroxide promotes after production through JNK-dependent activation of g-secretase. J Biol Chem 283, 17721-17730.
51. LoPachin RM, Gavin T, Petersen DR, Barber DS (2009) Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol 22, 1499-1508.
52. Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, Nathan PJ (2001) The chronic effects of an extract ofBacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacol (Berl) 156, 481-484. (Pubitemid 32695859)
53. Maher BF, Stough C, Shelmerdine A, Wesnes K, Nathan PJ (2002) The acute effects ofcombined administration ofGinkgo biloba and Bacopa monniera on cognitive function in humans. Hum Psychopharmacol 17, 163-164.
54. Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J (2002) Chronic effects ofBrahmi (Bacopa monnieri) on human memory. Neuropsychopharmacol 27, 279-281.
55. Hota SK, Barhwal K, Baitharu I, Prasad D, Singh SB, Ilavazha-gan G (2009) Bacopa monniera leaf extract ameliorates hypo-baric hypoxia induced spatial memory impairment. Neurobiol Dis 34, 23-39.
56. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stress in a triple-transgenic mouse model ofAlzheimer disease. Free Radic Biol MedUSA 44,2051-2057.
57. Boyd-Kimball D, Sultana R, Abdul HM, Butterfield DA (2005) Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 79, 700-706.
58. Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T, Kawahara N (2001) Bacopaside, Bacopaside I and II: two psedojujubogenin glycosides from B monniera. Phytochem Anal 58, 553-556.
59. Murthy PB, Raju VR, Ramakrisana T, Chakravarthy MS, Kumar KV, Kannababu S, Subbaraju GV (2006) estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem PharmBull (Tokyo) 54, 907-911.
60. Deepak M, Sangli GK, Arun PC, Amit A (2005) Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal 16, 24-29.
61. Luo J, Robinson JP, Shi R (2005) Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int 47, 449-457.
62. Pocernich CB, Butterfield DA (2003) Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 5, 515-520.
63. Nulton-Persson AC, Szweda LI (2001) Modulation of mito-chondrial function by hydrogen peroxide. J Biol Chem 276, 23357-23361.
64. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA (2002) β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80, 91-100.
65. Sultana R, Perluigi M, Newman SF, Pierce W, Cini C, Coc-cia R, Butterfield DA (2009) Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antiox Redox Signal 12, 327-336.
66. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signalling. Cell 132, 344-362.
67. Longpre F, Garneau P, Christen Y, Ramassamy C (2006) Protection by EGb 761 against ft-amyloid-induced neurotoxicity: Involvement of NF-KB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med 41, 1781-1794.
68. Buggia-Prevot V, Sevalle J, Rossner S, Checler F (2008) NFkappaB-dependent control of BACE1 promoter transacti-vation by Abeta42. J Biol Chem 283, 10037-10047.
69. Collister KA, Albensi BC (2005) Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease. Drug News Perspect 18, 623-629.
70. Tanel A, Averill-Bates DA (2007) P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cell Signal 19, 968-977.
71. Swatton JE, Sellers LA, Faull RL, Holland A, Iritani S, and Bahn S (2004) Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur J Neurosci 19, 2711-2719.
72. Liu W, Akhand AA, Takeda K, Kawamoto Y, Itoigawa M, Kato M, Suzuki H, Ishikawa N, Nakashima I (2003) Protein phosphatase 2A-linked and-unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ 10, 772-781.
73. Jang JH, Surh YJ (2005) Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway. Free Radic Biol Med 38, 1604-1613.
74. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EM-BO J 23, 2369-2380.
75. Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr, Bennett DA, Calon F (2009) Sirtuin1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68, 48-58.
76. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sa-doshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinet-ti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281, 21745-21754.
77. Albani D, Polito L, Batelli S, Mauro SD, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by isn't in document-synuclein or amyloid-ft (1-42) peptide. J Neurochem 110, 1445-1456.
78. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
79. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pan-dolfi PP, Lanfrancone L, Pelicci PG (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313.
80. Camici GG, Sudano I, Noll G, Tanner FC, Luscher TF (2009) Molecular pathways of aging and hypertension. Curr Opin Nephrol Hypertens 18, 134-137.
81. Hu Y, Wang X, Zeng L, Cai DY, Sabapathy K, Goff SP, Fir-po EJ, Li B (2005) ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell 16, 3705-3718.
82. Cleren C, Calingasan NY, Chen J, Beal MF (2005) Celas-trol protects against MPTP-and 3-nitropropionic acid-induced neurotoxicity. J Neurochem 94, 95-1004.
83. Jung HW, Chung YS, Kim YS, Park YK (2007) Celastrol inhibits production of nitric oxide and proinflammatory cy-tokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp Mol Med 39, 715-721.
84. Ramassamy C, Longpre F, Christen Y (2007) Ginkgo biloba extract (EGb761) in Alzheimer's disease: is there any evidence? Curr Alzheimer Res 4, 253-262.
85. Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R (2000) The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 12, 1882-1890.